Serum Markers of Inflammation Mediate the Positive Association Between Neuroticism and Depression
Open Access
- 20 November 2018
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Psychiatry
- Vol. 9, 609
Abstract
Background: The personality trait neuroticism has been implicated in a poor response to stress, may relate to increased concentrations of cytokines and the development of depression. Inflammatory mechanisms may also be associated with the onset, severity and symptoms of depression. Both are related to poor antidepressant treatment outcome. Therefore, mediators of inflammation may bridge the relationship between neuroticism and depression. Methods: To disentangle these interrelationships, the associations between neuroticism (according to NEO-PIR-N), depressive symptoms (BDI-II scores) and serum levels of hsCRP, TNF-α, IFN-γ, IL-2, IL-4, IL-5, IL-10, IL-12, IL-13, GM-CSF were investigated in a group of 212 participants, consisting of 37 depressed and 175 non-depressed subjects. A mediation model was used to investigate whether the impact of neuroticism on depressive symptoms may be mediated by cytokines. Results: Regression analyses revealed that IFN-γ, IL-5, and IL-12-levels, but none of the anti-inflammatory cytokines, were associated with the overall neuroticism score and several of the cytokines were related to the different facets of neuroticism. TNF-α, IFN-γ, IL-5, IL-12, and IL-13 were further related to the severity of depressive symptoms, as well as the somatic-affective and the cognitive dimensions of depression. Pro-inflammatory IFN-γ, IL-5 and IL-12 were identified as mediators of the positive prediction of depression severity by the degree of neuroticism. Conclusions: The current findings demonstrate that conditions related to long-term stress, such as depression and high neuroticism, are related to an up-regulation of inflammatory agents. Neuroticism may increase stress perception and, thus, increase the production of pro-inflammatory messenger molecules which are involved in the development of depression. This evidence may contribute to future anti-inflammatory interventions, particularly in subjects with high neuroticism who are at risk for developing depression. Furthermore, depressed patients with high neuroticism and cytokine levels may require early escalations in the intensity of treatment, along with additional therapeutic elements to increase the rate of treatment success.Keywords
This publication has 50 references indexed in Scilit:
- A SYSTEMATIC REVIEW OF TUMOR NECROSIS FACTOR-α IN POST-TRAUMATIC STRESS DISORDER: EVIDENCE FROM HUMAN AND ANIMAL STUDIESPsychiatria Danubina, 2017
- Partially distinct combinations of psychological, metabolic and inflammatory risk factors are prospectively associated with the onset of the subtypes of Major Depressive Disorder in midlifeJournal of Affective Disorders, 2017
- Psychological Stress, Inflammation, and Coronary Heart DiseaseCurrent Cardiology Reports, 2017
- Neuroticism's prospective association with mental disorders halves after adjustment for baseline symptoms and psychiatric history, but the adjusted association hardly decays with time: a meta-analysis on 59 longitudinal/prospective studies with 443 313 participantsPsychological Medicine, 2016
- Pleiotropy between neuroticism and physical and mental health: findings from 108 038 men and women in UK BiobankTranslational Psychiatry, 2016
- The Role of Neuroticism in the Maintenance of Chronic Baseline Stress Perception and Negative AffectThe Spanish Journal of Psychology, 2016
- Five-factor model personality traits and inflammatory markers: New data and a meta-analysisPsychoneuroendocrinology, 2014
- Depression and neuroticism in patients with chronic hepatitis C: Correlation with peripheral blood mononuclear cells activationJournal of Clinical Virology, 2014
- Cytokines as biomarkers in depressive disorder: Current standing and prospectsInternational Review of Psychiatry, 2013
- Stress-induced cytokine changes in ratsEuropean Cytokine Network, 2013